139 related articles for article (PubMed ID: 4209534)
21. Regulation of tyrosinase activity in mouse melanoma and skin by changes in melanosomal membrane permeability.
Van Woert MH; Korb F; Prasad KN
J Invest Dermatol; 1971 May; 56(5):343-8. PubMed ID: 4997370
[No Abstract] [Full Text] [Related]
22. Tyrosine release and tyrosinase activity in amelanotic and melanotic malignant melanoma.
Satoh GJ; Mishima Y
J Invest Dermatol; 1969 Jan; 52(1):107-10. PubMed ID: 4973526
[No Abstract] [Full Text] [Related]
23. [Electron microscope study of the origin of premelanosomes in melanoma cells in vitro].
Stanka P; Kinzel V; Mohr U
Virchows Arch B Cell Pathol; 1969; 2(2):91-102. PubMed ID: 4978625
[No Abstract] [Full Text] [Related]
24. Melanization and tyrosinase activity.
Seiji M; Miyazaki K
J Invest Dermatol; 1971 Nov; 57(5):316-22. PubMed ID: 5001257
[No Abstract] [Full Text] [Related]
25. Inability of murine melanoma melanosomal "tyrosinase" (L-dopa oxidase) to oxidize tyrosine to melanin in polyacrylamide gel systems.
Edelstein LM; Cariglia N; Okun MR; Patel RP; Smucker D
J Invest Dermatol; 1975 May; 64(5):364-70. PubMed ID: 806638
[TBL] [Abstract][Full Text] [Related]
26. Control of pigment production in mouse melanoma cells in vitro. Evocation and maintenance.
Silagi S
J Cell Biol; 1969 Nov; 43(2):263-74. PubMed ID: 4981070
[TBL] [Abstract][Full Text] [Related]
27. Stimulation of tyrosinase activity and melanin formation of cultured melanoma cells by serum deprivation alone or in combination with dibutyryl cyclic AMP and theophylline.
Leising HB; Schachtschabel DO
Z Naturforsch C Biosci; 1977; 32(7-8):567-72. PubMed ID: 198988
[TBL] [Abstract][Full Text] [Related]
28. Melanogenesis in melanoma cells in tissue culture.
Seiji M; Tanahashi Y; Oikawa A
Tohoku J Exp Med; 1972 Jul; 107(3):203-16. PubMed ID: 4674240
[No Abstract] [Full Text] [Related]
29. Response of mouse melanoma cells to melanocyte stimulating hormone.
Wong G; Pawelek J; Sansone M; Morowitz J
Nature; 1974 Mar; 248(446):351-4. PubMed ID: 4362188
[No Abstract] [Full Text] [Related]
30. The tyrosinase activity of melanosomes from the Harding-Passey melanoma: the absence of a peroxidase component in vitro.
Mufson RA
Arch Biochem Biophys; 1975 Apr; 167(2):738-43. PubMed ID: 804863
[No Abstract] [Full Text] [Related]
31. Functional analysis of tyrosinase isozymes of cultured malignant melanoma cells during the recovery period following interrupted melanogenesis induced by glycosylation inhibitors.
Imokawa G; Mishima Y
J Invest Dermatol; 1984 Sep; 83(3):196-201. PubMed ID: 6432920
[TBL] [Abstract][Full Text] [Related]
32. The role of adenosine 3',5'-cyclic monophosphate in the density-dependent regulation of growth and tyrosinase activity of B-16 melanoma cells.
Wade DR; Burkart ME
J Cell Physiol; 1978 Mar; 94(3):265-73. PubMed ID: 202603
[TBL] [Abstract][Full Text] [Related]
33. A revised concept of mammalian melanogenesis: the possible synergistic functions of aerobic dopa oxidase and peroxidase. A review.
Okun MR; Edelstein LM; Patel RP; Donnellan B
Yale J Biol Med; 1973 Dec; 46(5):535-40. PubMed ID: 4205120
[No Abstract] [Full Text] [Related]
34. Melanocyte function: influence of cyclic adenosine monophosphate.
McGuire J
Clin Pharmacol Ther; 1974 Nov; 16(5 Part 2):954-8. PubMed ID: 4371308
[No Abstract] [Full Text] [Related]
35. [Study of the proteins and isoenzymes of melanomas by the method of agar gel electrophoresis].
Diachenk VK; Gavrilenko IS
Vopr Onkol; 1967; 13(12):44-6. PubMed ID: 4970402
[No Abstract] [Full Text] [Related]
36. Effect of phenothiazines on melanoma tyrosinase activity.
Van Woert MH
J Pharmacol Exp Ther; 1970 Jun; 173(2):256-64. PubMed ID: 4988494
[No Abstract] [Full Text] [Related]
37. Intracellular localization of tyrosinase inhibitor in amelanotic and melanotic malignant melanoma.
Hamada T; Mishima Y
Br J Dermatol; 1972 Apr; 86(4):385-94. PubMed ID: 4623455
[No Abstract] [Full Text] [Related]
38. Suppression of melanoma cell tyrosinase activity and tumorigenicity after incorporation of bromouracil for one or two cell divisions.
Wrathall JR; Newcomb EW; Balint R; Zeitz L; Silagi S
J Cell Physiol; 1975 Dec; 86 Suppl 2(3 Pt 2):581-92. PubMed ID: 811676
[TBL] [Abstract][Full Text] [Related]
39. [Active tyrosinase sites in melanin synthesizing cells; biochemical analysis of coated vesicles (author's transl)].
Imokawa G; Mishima Y
Nihon Hifuka Gakkai Zasshi; 1978 Nov; 88(13):913-30. PubMed ID: 104070
[No Abstract] [Full Text] [Related]
40. Melanogenuria as consequence of elevated tyrosinase activity in melanoma.
Duchon J; Matous B; Pavel S
Acta Univ Carol Med Monogr; 1977; (78 Pt 2):139-44. PubMed ID: 97931
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
